Cargando…
Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204221/ https://www.ncbi.nlm.nih.gov/pubmed/25340089 http://dx.doi.org/10.1212/NXI.0000000000000038 |
| _version_ | 1782340523593302016 |
|---|---|
| author | Fujihara, Kazuo Nakashima, Ichiro |
| author_facet | Fujihara, Kazuo Nakashima, Ichiro |
| author_sort | Fujihara, Kazuo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4204221 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42042212014-10-22 Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy? Fujihara, Kazuo Nakashima, Ichiro Neurol Neuroimmunol Neuroinflamm Editorial Lippincott Williams & Wilkins 2014-10-09 /pmc/articles/PMC4204221/ /pubmed/25340089 http://dx.doi.org/10.1212/NXI.0000000000000038 Text en © 2014 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially. |
| spellingShingle | Editorial Fujihara, Kazuo Nakashima, Ichiro Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy? |
| title | Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy? |
| title_full | Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy? |
| title_fullStr | Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy? |
| title_full_unstemmed | Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy? |
| title_short | Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy? |
| title_sort | secondary progression and innate immunity in nmo: a possible link to alemtuzumab therapy? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204221/ https://www.ncbi.nlm.nih.gov/pubmed/25340089 http://dx.doi.org/10.1212/NXI.0000000000000038 |
| work_keys_str_mv | AT fujiharakazuo secondaryprogressionandinnateimmunityinnmoapossiblelinktoalemtuzumabtherapy AT nakashimaichiro secondaryprogressionandinnateimmunityinnmoapossiblelinktoalemtuzumabtherapy |